Revisiting Resveratrol As an Osteoprotective Agent: Molecular Evidence from In Vivo and In Vitro Studies

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 May 27

PMID 37239124

Authors

Haryati Ahmad Hairi

Putri Ayu Jayusman

Ahmad Nazrun Shuid

Affiliations

Soon will be listed here.

Abstract

Resveratrol (RSV) (3,5,4'-trihydroxystilbene) is a stilbene found in abundance in berry fruits, peanuts, and some medicinal plants. It has a diverse range of pharmacological activities, underlining the significance of illness prevention and health promotion. The purpose of this review was to delve deeper into RSV's bone-protective properties as well as its molecular mechanisms. Several in vivo studies have found the bone-protective effects of RSV in postmenopausal, senile, and disuse osteoporosis rat models. RSV has been shown to inhibit NF-κB and RANKL-mediated osteoclastogenesis, oxidative stress, and inflammation while increasing osteogenesis and boosting differentiation of mesenchymal stem cells to osteoblasts. Wnt/β-catenin, MAPKs/JNK/ERK, PI3K/AKT, FoxOs, microRNAs, and BMP2 are among the possible kinases and proteins involved in the underlying mechanisms. RSV has also been shown to be the most potent SIRT1 activator to cause stimulatory effects on osteoblasts and inhibitory effects on osteoclasts. RSV may, thus, represent a novel therapeutic strategy for increasing bone growth and reducing bone loss in the elderly and postmenopausal population.

Citing Articles

Morin Improves the Bone Histomorphology and Biochemical Markers in an Animal Model of Ovariectomy-Induced Osteoporosis by Suppressing Autophagy and Apoptosis.

Jiang N, Qi B, Li G, Yao L, Fan X Food Sci Nutr. 2024; 12(12):10099-10109.

PMID: 39723054 PMC: 11666969. DOI: 10.1002/fsn3.4554.

Primary Osteoporosis Induced by Androgen and Estrogen Deficiency: The Molecular and Cellular Perspective on Pathophysiological Mechanisms and Treatments.

Hsu S, Chen L, Chen K Int J Mol Sci. 2024; 25(22).

PMID: 39596206 PMC: 11593909. DOI: 10.3390/ijms252212139.

Nutraceuticals in osteoporosis prevention.

Roseti L, Borciani G, Grassi F, Desando G, Gambari L, Grigolo B Front Nutr. 2024; 11:1445955.

PMID: 39416651 PMC: 11479890. DOI: 10.3389/fnut.2024.1445955.

Resveratrol enhances the protective effects of calcium supplements on spinal cord injury-induced osteoporosis by targeting the SIRT1/FOXO3a pathway.

Zhong Q Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39287671 DOI: 10.1007/s00210-024-03412-0.

Microbiota and Resveratrol: How Are They Linked to Osteoporosis?.

Meyer C, Brockmueller A, Ruiz de Porras V, Shakibaei M Cells. 2024; 13(13.

PMID: 38994996 PMC: 11240679. DOI: 10.3390/cells13131145.

References

Foger-Samwald U, Kerschan-Schindl K, Butylina M, Pietschmann P . Age Related Osteoporosis: Targeting Cellular Senescence. Int J Mol Sci. 2022; 23(5). PMC: 8910503. DOI: 10.3390/ijms23052701. View

Agas D, Marchetti L, Hurley M, Sabbieti M . Prostaglandin F2α: a bone remodeling mediator. J Cell Physiol. 2012; 228(1):25-9. DOI: 10.1002/jcp.24117. View

Fakhry M, Hamade E, Badran B, Buchet R, Magne D . Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells. 2013; 5(4):136-48. PMC: 3812518. DOI: 10.4252/wjsc.v5.i4.136. View

Lee A, Shandala T, Soo P, Su Y, King T, Chen K . Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss. Nutrients. 2017; 9(3). PMC: 5372918. DOI: 10.3390/nu9030255. View

Wen A, Sakamoto K, Miller L . The role of the transcription factor CREB in immune function. J Immunol. 2010; 185(11):6413-9. PMC: 5519339. DOI: 10.4049/jimmunol.1001829. View

Guo D, Han Y, Cong L, Liang D, Tu G . Resveratrol prevents osteoporosis in ovariectomized rats by regulating microRNA-338-3p. Mol Med Rep. 2015; 12(2):2098-106. DOI: 10.3892/mmr.2015.3581. View

Zainabadi K, Liu C, Caldwell A, Guarente L . SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis. PLoS One. 2017; 12(9):e0185236. PMC: 5609767. DOI: 10.1371/journal.pone.0185236. View

Garone C, Pietra A, Nesci S . From the Structural and (Dys)Function of ATP Synthase to Deficiency in Age-Related Diseases. Life (Basel). 2022; 12(3). PMC: 8949411. DOI: 10.3390/life12030401. View

Yousefzadeh N, Kashfi K, Jeddi S, Ghasemi A . Ovariectomized rat model of osteoporosis: a practical guide. EXCLI J. 2020; 19:89-107. PMC: 7003643. DOI: 10.17179/excli2019-1990. View

10.

Black D, Condra K, Adams A, Eastell R . Bisphosphonates and the risk of atypical femur fractures. Bone. 2021; 156:116297. DOI: 10.1016/j.bone.2021.116297. View

11.

Yuan J, Dong X, Yap J, Hu J . The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. J Hematol Oncol. 2020; 13(1):113. PMC: 7433213. DOI: 10.1186/s13045-020-00949-4. View

12.

Dai Z, Li Y, Quarles L, Song T, Pan W, Zhou H . Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 2007; 14(12):806-14. DOI: 10.1016/j.phymed.2007.04.003. View

13.

Hooshiar S, Tobeiha M, Jafarnejad S . Soy Isoflavones and Bone Health: Focus on the RANKL/RANK/OPG Pathway. Biomed Res Int. 2022; 2022:8862278. PMC: 9626210. DOI: 10.1155/2022/8862278. View

14.

Sun W, Qiao W, Zhou B, Hu Z, Yan Q, Wu J . Overexpression of Sirt1 in mesenchymal stem cells protects against bone loss in mice by FOXO3a deacetylation and oxidative stress inhibition. Metabolism. 2018; 88:61-71. DOI: 10.1016/j.metabol.2018.06.006. View

15.

Cheng C, Chen L, Chen K . Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. Int J Mol Sci. 2022; 23(3). PMC: 8836058. DOI: 10.3390/ijms23031376. View

16.

Borsani E, Bonazza V, Buffoli B, Nocini P, Albanese M, Zotti F . Beneficial Effects of Concentrated Growth Factors and Resveratrol on Human Osteoblasts Treated with Bisphosphonates. Biomed Res Int. 2018; 2018:4597321. PMC: 5976957. DOI: 10.1155/2018/4597321. View

17.

Bo S, Gambino R, Ponzo V, Cioffi I, Goitre I, Evangelista A . Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial. Nutr Diabetes. 2018; 8(1):51. PMC: 6147949. DOI: 10.1038/s41387-018-0059-4. View

18.

Ma J, Wang Z, Zhao J, Miao W, Ye T, Chen A . Resveratrol Attenuates Lipopolysaccharides (LPS)-Induced Inhibition of Osteoblast Differentiation in MC3T3-E1 Cells. Med Sci Monit. 2018; 24:2045-2052. PMC: 5903312. DOI: 10.12659/msm.905703. View

19.

Zainabadi K . The variable role of SIRT1 in the maintenance and differentiation of mesenchymal stem cells. Regen Med. 2018; 13(3):343-356. DOI: 10.2217/rme-2017-0128. View

20.

Park J, Lee N, Lee S . Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation. Mol Cells. 2017; 40(10):706-713. PMC: 5682248. DOI: 10.14348/molcells.2017.0225. View